Erosion of the Right Atrial Wall After Implantation of a Patch-Like Septal Occluder Authors: Jochen Grohmann, Yannic Wilberg, Eugen Sandica, Stephan Schubert, Johanna Hummel Published: 2026 ABSTRACT AbstractCase SummaryPercutaneous closure of secundum-type atrial septal defects (ASDs) using patch-like Gore devices is anticipated to be safe, even in deficient rims. Here, however, we report the first case of atrial wall erosion following a technically straightforward and successful Gore cardioform ASD occluder implantation since its Food and Drug Administration and European Conformity approval. We conclude that, in principle, any device can cause mechanical erosion of the atrial wall, especially since the unpredictable extent of right atrial remodeling after unloading or the varying integrity of the atrial wall texture must be taken into account as unknown factors.Take-Home MessagesIn general, even patch-like Gore ASD devices can cause mechanical erosion of the atrial wall. Because the risk of erosion is highest within the first 1 to 6 months, consistent follow-up in the outpatient department is mandatory regardless of which ASD device has been used.Key words: atrial septal defect, occluder, pericardial effusion Case Summary A patient aged 12 is presented with a hemodynamically significant atrial septal defect (ASD II), pulmonary hypertension, severe scoliosis, and trisomy 21. Cardiac catheterization guided by transesophageal echocardiography revealed a multiperforated oval fossa with a 12 × 16-mm main defect (balloon sized 18 × 18 mm), with the posterior rim appearing borderline at 5 to 6 mm (Figure 1A). Following balloon test occlusion, which demonstrated response to pulmonary hypertension–modulating medication (mean pulmonary artery pressure dropped from 25 to 17 mm Hg), ASD-device closure was performed with a Gore ASD Occluder (GCA 32 mm) in a straightforward manner. Finally, a reasonable device position was achieved (Figure 1B), as well as a consistently acceptable pulmonary artery pressure (mean pulmonary artery pressure 19, pulmonary capillary wedge pressure 11 mm Hg). Transesophageal Echocardiography (A) Retroaortically, the main native ASD II measures 15 mm in diameter, with its posterior margin appearing borderline at 6 mm; (B) following release, GCA 32 mm with both discs well aligned towards the atrial septum; fluoroscopic view; (C) GCA actually oriented more horizontally due to scoliosis. CT scan on f/u; (D) with density values averaging 30 to 40 HU, hemorrhagic pericardial effusion adjacent to the correctly positioned and configured GCA. Intraoperative findings: (E) a small perforation, circled in blue, on the lateral wall of the right atrium caused by the GCA. Fluoroscopy: (F) explanted GCA w/o any wire frame fractures. ASD = atrial septal defect; CT = computed tomography; GCA = Gore cardioform ASD occluder. However, a follow-up examination after 6 weeks revealed a large pericardial effusion behind the right atrium; fortunately, the patient's clinical course had been uneventful up to that point. The GCA device was unchanged in situ and showed no signs of malfunction, both disks were well aligned, and no obvious atrial wall perforation was observed. However, the effusion's echogenicity suggested a hemopericardium, consistent with computed tomography findings (average density values of 35.8 HU) (Figure 1D). Consequently, open heart surgery was indicated, during which erosion was observed on the right atrium's posterolateral wall, caused by the adjacent GCA disc (Figure 1F). Once the device had been completely removed, the perforation was over-sewn, and the ASD was closed using a patch. The postoperative course was uneventful. Discussion Device closure is the treatment of choice for hemodynamically significant ASD II. Although device-related erosion is very rare, its actual incidence is not precisely known. Its occurrence is generally unpredictable, meaning that 100% prevention cannot be guaranteed. Implantation of patch-like Gore devices into the atrial septum is anticipated to be safe, even in deficient rims, as the soft polytetrafluoroethylene-covered frame can embrace the aorta without exerting significant forces on the aortic root or atrial roof.1 However, this is the first reported GCA-related atrial wall erosion following a technically straightforward GCA implantation since its Food and Drug Administration and European Conformity approval. It is noteworthy that the size of the implanted GCA was based on instructions for use recommendations, and wire frame fractures were excluded as a potential cause for sequelae (Figure 1E). Speculatively, the altered position of the heart caused by our patient's scoliosis may have altered the shape of the atrial septum such that the GCA's frame dug into the RA free wall more than it normally would (Figure 1C). However, we conclude that any ASD device can cause erosion, apparently regardless of its design, presumably as a result of increasing disk interaction or even friction, since the unpredictable extent of right atrial remodeling following unloading or the varying integrity of the atrial wall texture must be taken into account as unknown factors. Contrary to previous assumptions, inadequate rims can also pose a limitation for patch-like devices.2,3 Funding Support and Author Disclosures Dr Schubert has received fees for educational events and proctoring for Medtronic. Drs Hummel and Grohmann have received fees for educational events for Medtronic. The other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Take-Home Messages •In general, even patch-like Gore atrial septal defect devices can cause mechanical erosion of the atrial wall. In general, even patch-like Gore atrial septal defect devices can cause mechanical erosion of the atrial wall. •Because the risk of erosion is highest within the first 1 to 6 months, consistent follow-up in the outpatient department is mandatory regardless of which ASD device has been used. Because the risk of erosion is highest within the first 1 to 6 months, consistent follow-up in the outpatient department is mandatory regardless of which ASD device has been used. Footnotes The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. Appendix For supplemental videos, please see the online version of this paper. Appendix Video 1 On Transesophageal Echocardiography, the Native Atrial Septal Defect II Is Shown, With Its Posterior Rim Appearing Borderline Video 2 Retroaortic View of the Large Atrial Septal Defect II and the Borderline Posterior Rim Video 3 Gore Cardioform ASD Occluder Deployment Under Transesophageal Echocardiography Guidance Video 4 Gore Cardioform ASD Occluder Deployment Under Fluoroscopic Guidance Video 5 Gore-Typical Release-Jump-Phenomenon on Transesophageal Echocardiography Video 6 Gore-Typical Release-Jump Phenomenon Under Fluoroscopy Video 7 Complete Removal of Both the Safety Cord and the Delivery System Video 8 Result After Gore Cardioform ASD Occluder Implantation, Focusing on Its Interaction With the Posterior Atrial Wall Segments on Transesophageal Echocardiography Video 9 Transesophageal Echocardiography After Readmission Showing Pericardial Effusion and the Device Still in Place References Associated Data Supplementary Materials Video 1 On Transesophageal Echocardiography, the Native Atrial Septal Defect II Is Shown, With Its Posterior Rim Appearing Borderline Video 2 Retroaortic View of the Large Atrial Septal Defect II and the Borderline Posterior Rim Video 3 Gore Cardioform ASD Occluder Deployment Under Transesophageal Echocardiography Guidance Video 4 Gore Cardioform ASD Occluder Deployment Under Fluoroscopic Guidance Video 5 Gore-Typical Release-Jump-Phenomenon on Transesophageal Echocardiography Video 6 Gore-Typical Release-Jump Phenomenon Under Fluoroscopy Video 7 Complete Removal of Both the Safety Cord and the Delivery System Video 8 Result After Gore Cardioform ASD Occluder Implantation, Focusing on Its Interaction With the Posterior Atrial Wall Segments on Transesophageal Echocardiography Video 9 Transesophageal Echocardiography After Readmission Showing Pericardial Effusion and the Device Still in Place